Select your language
01.08.2025
Tuberculosis (TB) is a major threat to public health and is among the leading causes of death worldwide, according to the World Health Organization. The emergence of drug-resistant TB and current standard of long treatment regimens have increased the urgent need for new, more effective therapies.
25.07.2025
A major international clinical trial published this week in The Lancet Respiratory Medicine has assessed the efficacy and safety of a novel, shortened treatment regimen for patients with pre-extensively drug-resistant tuberculosis (pre-XDR TB)—a form of tuberculosis that is resistant to both rifampicin and fluoroquinolones.
17.07.2025
A landmark multinational study published in The Lancet Regional Health – Europe has revealed that only 40% of patients with extensively drug-resistant tuberculosis (XDR-TB) in the WHO European Region achieved successful treatment outcomes.
14. - 17. September 2025
University Vienna, Institute of Analytical Chemistry, 1090 Vienna, Austria
08. Oktober 2025Borstel
16. Oktober 2025online